HEMANGIOMA

Clinical trials for HEMANGIOMA explained in plain language.

Never miss a new study

Get alerted when new HEMANGIOMA trials appear

Sign up with your email to follow new studies for HEMANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare, dangerous blood vessel tumors after other drugs fail

Disease control Not yet recruiting

This study is testing a drug called everolimus for people with rare, non-cancerous blood vessel growths and tumors that have not improved with standard treatments. It will enroll 67 patients, including children as young as 1 year old, who have already tried at least one other the…

Matched conditions: HEMANGIOMA

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

HEMANGIOMA

Get alerted when new HEMANGIOMA trials appear

New hope for rare, dangerous blood vessel tumors after other drugs fail